Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report

Abstract Background Novel immune checkpoint inhibitors have been often utilized for different types of malignancies as salvage therapy with varying success. One obstacle to immune checkpoint inhibitor use is the higher incidence of immune-mediated side effects that can prompt discontinuation of ther...

Full description

Bibliographic Details
Main Authors: Linh Ngo, Eric Miller, Peter Valen, Elie Gertner
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Journal of Medical Case Reports
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13256-018-1579-1